5-HT7–TrkB Heteroreceptor Complexes: A Novel Molecular Pathway May Contribute to the Antidepressant-like Effects of 5-HT7 Receptor Activation

Serotonin receptor 5-HT7 and tropomyosin receptor kinase B (TrkB) are both key regulators of neuroplasticity implicated in the pathophysiology and treatment of depression. Although functional crosstalk between these receptors has been suggested, the underlying molecular mechanism remains unknown. Here, we investigated the physical and functional interaction between 5-HT7 and TrkB receptors at behavioral, biochemical, and molecular levels. Using males of the antidepressant-sensitive cataleptic (ASC) mouse model of depressive-like behavior, we demonstrated that repeated (9 days) activation of 5-HT7 receptors with the selective agonist LP-211 produced antidepressant-like effects in the sucrose preference test. These behavioral effects were dependent on TrkB signaling, as it was prevented by pretreatment with the TrkB antagonist ANA12. Both acute and repeated 5-HT7 receptor activation increased TrkB phosphorylation in the mouse brain, although this long-term effect was brain region- and amino acid residue-specific. To determine if these functional interactions were mediated by a direct physical association, we used co-immunoprecipitation and FRET assays. We found that 5-HT7 and TrkB form heteroreceptor complexes in vitro in neuroblastoma cells and in vivo in the mouse frontal cortex, hippocampus, and midbrain. Collectively, our findings support an oligomerization between 5-HT7 and TrkB receptors and suggest that this association may contribute to the antidepressant-like effects of 5-HT7 receptor activation.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-13
DOI
https://doi.org/10.3390/ijms272210169
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

5-HT7–TrkB Heteroreceptor Complexes: A Novel Molecular Pathway May Contribute to the Antidepressant-like Effects of 5-HT7 Receptor Activation

Dmitry V. Eremin, Anton S. Tsybko, Tatiana V. Ilchibaeva, Vladimir S. Naumenko et al.
International Journal of Molecular Sciences
Treatment of Major Depression
article

5-HT7–TrkB Heteroreceptor Complexes: A Novel Molecular Pathway May Contribute to the Antidepressant-like Effects of 5-HT7 Receptor Activation

Dmitry V. Eremin, Anton S. Tsybko, Tatiana V. Ilchibaeva, Vladimir S. Naumenko, Maria Shalagina
article en

Abstract

Serotonin receptor 5-HT7 and tropomyosin receptor kinase B (TrkB) are both key regulators of neuroplasticity implicated in the pathophysiology and treatment of depression. Although functional crosstalk between these receptors has been suggested, the underlying molecular mechanism remains unknown. Here, we investigated the physical and functional interaction between 5-HT7 and TrkB receptors at behavioral, biochemical, and molecular levels. Using males of the antidepressant-sensitive cataleptic (ASC) mouse model of depressive-like behavior, we demonstrated that repeated (9 days) activation of 5-HT7 receptors with the selective agonist LP-211 produced antidepressant-like effects in the sucrose preference test. These behavioral effects were dependent on TrkB signaling, as it was prevented by pretreatment with the TrkB antagonist ANA12. Both acute and repeated 5-HT7 receptor activation increased TrkB phosphorylation in the mouse brain, although this long-term effect was brain region- and amino acid residue-specific. To determine if these functional interactions were mediated by a direct physical association, we used co-immunoprecipitation and FRET assays. We found that 5-HT7 and TrkB form heteroreceptor complexes in vitro in neuroblastoma cells and in vivo in the mouse frontal cortex, hippocampus, and midbrain. Collectively, our findings support an oligomerization between 5-HT7 and TrkB receptors and suggest that this association may contribute to the antidepressant-like effects of 5-HT7 receptor activation.

International Journal of Molecular SciencesVol. 27(22)
Russian Academy of Sciences (RU), Institute of Cytology and Genetics (RU), Siberian Branch of the Russian Academy of Sciences (RU)
Russian Science Foundation
Good health and well-being
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon